Our perspective
Stay up to date with our opinion on the latest topics in the urologic oncology healthcare space. From AI to healthcare equality, we take a deeper look at the latest research to look towards the future of bladder cancer. Keep checking back for new articles.
Photocure raises awareness at EU Roundtable and Report on bladder cancer
In April 2025 the International Centre for Parliamentary Studies ICPS organized a senior-level roundtable on bladder cancer with leading clinicians, industry experts from Photocure and J&J Innovative Medicine, the European Association of Urology and the World Bladder Cancer Patient Coalition. The resulting recommendations for EU & Member State policymakers are published in this Government Gazette Healthcare Report, (bladder cancer: p. 33) featuring Photocure’s expert opinion:
- Equal access to advanced technologies to identify tumors in the bladder reduces burden on patients and healthcare systems.
- Bladder cancer is one of the costliest cancers to treat
- Precision medicine requires a precise diagnosis first
How AI is transforming early bladder cancer care
Over the past few years, artificial intelligence (AI) has gone from the subject of sci-fi movies to real-life application. As its use now expands into healthcare, we are seeing a transformation in approaches to diagnosis, treatment planning and decision making.
So, how can AI and diagnostic technologies help when it comes to the care pathway in non-muscle-invasive bladder cancer (NMIBC)?
Addressing inequality in bladder cancer care
Multiple analyses have revealed worrying gaps in bladder cancer outcomes and raised questions over disparities in quality of care. How can Photocure help uncover these disparities and how can real world evidence play a part in supporting healthcare equality?